Nick West

Showing 1-12 of 12 articles

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Coronary interventions

OPtical Coherence Tomography Guided Coronary Stent IMplantation Compared to Angiography: A Multicenter Randomized TriaL in PCI – Design and Rationale of ILUMIEN IV: OPTIMAL PCI

Ali Z, Landmesser U, Karimi Galougahi K, Maehara A, Matsumura M, Shlofmitz R, Guagliumi G, Price M, Hill JM, Akasaka T, Prati F, Bezerra H, Wijns W, Mintz G, Ben-Yehuda O, McGreevy RJ, Zhang Z, Rapoza RJ, West N, Stone G

September 1, 2020 | 10.4244/EIJ-D-20-00501

Coronary interventions

Outcomes of Optical Coherence Tomography Compared With Intravascular Ultrasound and With Angiography to Guide Coronary Stent Implantation: One-Year Results from the ILUMIEN III: OPTIMIZE PCI trial

Ali Z, Karimi Galougahi K, Maehara A, Shlofmitz R, Fabbiocchi F, Guagliumi G, Alfonso F, Akasaka T, Matsumura M, Mintz G, Ben-Yehuda O, Zhang Z, Rapoza RJ, West N, Stone G

June 15, 2020 | 10.4244/EIJ-D-20-00498

Coronary interventions

Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five years clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabate M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys P

June 9, 2020 | 10.4244/EIJ-D-20-00024

Coronary interventions

Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Włodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

May 26, 2020 | 10.4244/EIJ-D-19-01079

Coronary interventions

Clinical outcomes of bioresorbable vascular scaffolds implanted with routine versus selective optical coherence tomography guidance: results from a single-centre experience

Flore V, Brown A, Giblett J, Liou K, Cranley J, Hoole S, West N

April 16, 2019 | 10.4244/EIJ-D-18-00262

Stents and scaffolds

Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry

Baumbach A, Zaman A, West N, O’ Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, de Belder A, Bouras G, Lansky A, Hill J, Mathur A, De Belder M, Banning A

January 19, 2018 | 10.4244/EIJ-D-17-00886

Coronary interventions

Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage

Giblett J, Brown A, Keevil H, Jaworski C, Hoole S, West N

August 20, 2016 | 10.4244/EIJV12I6A117

Cholesterol crystals identified using optical coherence tomography and virtual histology intravascular ultrasound

Brown A, Obaid D, West N, Goddard M, Bennett M

June 19, 2015 | 10.4244/EIJV11I2A38

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K

July 26, 2013 | 10.4244/EIJV9I3A52

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D

May 15, 2012 | 10.4244/EIJV8I1A17

Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging

van Gaal W, Arnold J, Testa L, Karamitsos T, Lim C, Ponnuthurai F, Petersen S, Francis J, Selvanayagam J, Sayeed R, West N, Westaby S, Neubauer S, Banning A

January 20, 2011

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

An Occlutech PLD Occluder 8×4 mm is positioned through a 7 Fr catheter

November 20, 2020

Impact of Pulmonary Ridge Coverage after Left Atrial Appendage Occlusion

November 18, 2020

Lifelong learning never stops. PCR London Valves goes virtual!

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Patient preferences and Heart Team decision

November 20, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease